Corporate Banner
Satellite Banner
Next Gen Sequencing
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Takeda Selects Genedata Expressionist for Genomic Profiling

Published: Friday, July 13, 2012
Last Updated: Friday, July 13, 2012
Bookmark and Share
Takeda Pharmaceutical expands use of Genedata Expressionist by adding solution for next-generation sequencing data analysis.

Genedata has announced that Takeda Pharmaceutical Company expanded its collaboration with Genedata by licensing Genedata Expressionist for Genomic Profiling®. Takeda will use the solution to manage, analyze, and visualize massive amounts of raw data from next-generation sequencing (NGS), microarray, real time-PCR, and other genomic technologies. As an enterprise-level, high-throughput system that can simultaneously analyze thousands of experiments, Genedata Expressionist for Genomic Profiling integrates genomics, transcriptomics, epigenetics, and phenotypic data. Enabling Takeda to trace data and results while promoting standardization and reproducibility of experiments, Genedata Expressionist for Genomic Profiling helps Takeda advance its biomarker discovery projects.

“For many years, Takeda has relied on Genedata Expressionist for Mass Spectrometry for our biomarker discovery, and we have enjoyed a long-standing and collaborative relationship with Genedata,” noted a Takeda scientist in charge of bioinformatics research. “We searched for a solution to analyze NGS data that could be integrated with our other mass-spectrometry-based omics activities. Genedata Expressionist for Genomic Profiling uniquely handles high-throughput data and its capabilities for interactive genome visualization – essentially a highly-intuitive genome browser – will prove especially valuable to our NGS analysis.”

Pharmaceutical companies such as Takeda are using Genedata Expressionist for Genomic Profiling in a range of applications including: personalized medicine; biomarker discovery for predicting drug efficacy and toxicity; characterization of cell lines, xenografts and other model systems; and molecular diagnostics based on genomic and transcriptomic analyses.

Big Data – Easily Handled
Built on open and flexible client-server architecture, Genedata Expressionist for Genomic Profiling thrives on large and complex experimental data sets from all major vendors and technology platforms. It helps to bridge the gap between biology and statistics by making advanced statistical tools, which can analyze the most complex life science data, accessible to a wide range of users. These statistical tools advance the understanding of biological systems and diseases with support for some of the following technologies:

• Genomics/DNA-Seq: quantification of SNPs and InDels; chromosome rearrangement and gene fusion; quality control of called variants; annotation of variants with dbSNP or other external sources; functional annotation of variants; and analysis of copy number variations.

• Transcriptomics/RNA-Seq: gene, exon, and transcript-level quantification and expression analysis; identification of transcripts, novel genes, and exons; differential expression analysis; and detection of RNA-editing.

• Epigenomics/ChIP-Seq/Methyl-Seq: peak detection; annotation of detected peak regions; quantification of DNA methylation from ChIP or bisulfite treated DNA experiments; and identification and annotation of differentially methylated sites.

“Takeda is a leading, global pharmaceutical company with whom we are proud to be expanding our successful and long-term relationship,” said Dr. Othmar Pfannes, CEO of Genedata. “This collaboration validates our strategy to position Genedata Expressionist as an integration platform for a number of different omics technologies. Supporting NGS projects is a major focus for Genedata and we are committed to working with innovative companies such as Takeda who are pioneering NGS for improved healthcare.”


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,500+ scientific posters on ePosters
  • More than 3,700+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Takara Bio Selects Genedata Software to Automate and Standardize NGS Data Analysis
Genedata Expressionist® for Genomic Profiling helps Takara Bio to manage, process, and analyze large NGS datasets.
Wednesday, November 05, 2014
LifeTech TaqMan Integrates with Genedata Expressionist for Genomic Profiling
Genedata partners with Life Technologies to expedite NGS data analysis and real-time PCR-based validation.
Thursday, November 15, 2012
Scientific News
Liquid Biopsies: Utilization of Circulating Biomarkers for Minimally Invasive Diagnostics Development
Market Trends in Biofluid-based Liquid Biopsies: Deploying Circulating Biomarkers in the Clinic. Enal Razvi, Ph.D., Managing Director, Select Biosciences, Inc.
DNA Damage Seen in Patients Undergoing CT Scanning
Along with the burgeoning use of advanced medical imaging tests over the past decade have come rising public health concerns about possible links between low-dose radiation and cancer.
Web App Helps Researchers Explore Cancer Genetics
Brown University computer scientists have developed a new interactive tool to help researchers and clinicians explore the genetic underpinnings of cancer.
New Research Advances Genetic Studies in Wildlife Conservation
‘Next-gen’ DNA sequencing of non-invasively collected hair expands field of conservation genetics.
Gene Testing Now Allows Precision Medicine for Thoracic Aneurysms
Researchers at the Aortic Institute at Yale have tested the genomes of more than 100 patients with thoracic aortic aneurysms, a potentially lethal condition, and provided genetically personalized care.
OGT’s Popular ESHG Workshop Free to View Online
Learn about the next generation of microarrays in one of the best attended workshops of the conference.
Discordant NIPT Test Results May Reflect Presence of Maternal Cancer
Results published in Journal of the American Medical Association.
Sperm RNA Test May Improve Evaluation of Male Infertility
To help resolve uncertainty—and guide prospective parents to the right fertility treatments—scientists propose the use of a new kind of fertility test. It involves examining sperm RNA by means of next-generation sequencing.
How the Mammoth Got its Wool
Evolutionary change in a gene reconstructed in the lab from the woolly mammoth was part of a suite of adaptations that allowed the mammoth to survive in harsh arctic environments, according to new research.
NuGEN Scientists Screen 400+ Genes for Fusion Events in Single Assay
Breakthrough proves efficacy of new sample preparation method that could accelerate cancer research and development of treatments and diagnostic tests.
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!